Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial. Collet JP, Van Belle E, Thiele H, Berti S, et al. Eur Heart J 2022 May 18. pii: 6587401. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Collet JP, Van Belle E, Thiele H, Berti S, et al. Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial. Eur Heart J 2022 May 18. pii: 6587401. doi: 10.1093.
PMID: 35583186